FDA Chief Counsel, Ad Division Concur On 94% Of Violation Letters, Troy Says

FDA's Office of the Chief Counsel concurs with 94% of the Division of Drug Marketing, Advertising & Communications' enforcement letters, Chief Counsel Daniel Troy said